What Causes Bipolar Disorder? Genetics, Biology, and Environmental Factors
Author: Ukrainian Psychological Hub · Published: October 9, 2026 · Editorial Policy
Bipolar disorder develops through a combination of inherited susceptibility, biological processes involved in mood regulation, and experiences or exposures that can influence when symptoms begin and how episodes unfold. Researchers have identified strong genetic contributions and several plausible biological pathways, while the precise cause of an individual person's illness usually cannot be established. There is no single bipolar gene, traumatic event, chemical imbalance, brain scan, or laboratory result that explains every case. National Institute of Mental Health · World Health Organization
The key distinction is between susceptibility to developing bipolar disorder, factors associated with the timing of a first episode, and triggers that precede a recurrence in someone already living with the condition. These are related questions, but research answering one does not automatically answer the others. A stressful event can precede mania without being a sufficient cause of bipolar I disorder; a genetic association can increase probability without determining anyone's future. Bortolato et al., 2017 · NIMH
For additional clinical context, see Is Bipolar Disorder Genetic? Family History and Heritability Explained and Bipolar Disorder and the Brain: What Neuroscience Can and Cannot Explain.
What Causes Bipolar Disorder? The Evidence in Brief
Current evidence supports a multifactorial model. Bipolar disorder is substantially heritable at the population level, and genomic discoveries implicate many variants across multiple biological pathways. Differences in brain structure, function, sleep–wake regulation, and responsiveness to stress are also observed. Environmental research links childhood adversity, significant stressors, and some substance exposures to increased risk or a more difficult course. The strength and meaning of these links differ across studies, and many environmental findings remain observational. O'Connell et al., 2025 · Bortolato et al., 2017 · McCarthy et al., 2022
Researchers distinguish several levels of explanation. Family and genetic studies describe inherited liability. Molecular and neuroscience studies investigate potential mechanisms. Longitudinal studies examine whether an exposure comes before an outcome. Clinical assessments identify the pattern of actual manic, hypomanic, and depressive episodes. Understanding these levels together is more informative than declaring any single factor the cause. NIMH · NICE guideline CG185
Genetics: Why Bipolar Disorder Runs in Families
Bipolar disorder is highly heritable, but heritability is not destiny
Family and twin studies consistently find that inherited differences account for a substantial share of variation in liability to bipolar disorder across the populations studied. A 2025 large-scale genomic investigation describes heritability estimates of roughly 60%–80% from prior research. That figure is a population-level statistical concept: it does not mean that 60%–80% of one person's illness was caused by genes or that the child of someone with bipolar disorder has a 60%–80% probability of receiving the diagnosis. O'Connell et al., 2025
Having a parent or sibling with bipolar disorder raises risk relative to a person without such a family history. The majority of people with an affected relative nevertheless do not necessarily develop the disorder. Identical twins can have different outcomes despite sharing nearly all inherited DNA, supporting the contribution of factors beyond inherited sequence. Family history is therefore relevant to clinical assessment and counseling, but it cannot settle an individual's diagnosis. MedlinePlus Genetics · NIMH
Shared family environments, the health and exposures of relatives, patterns of recognition and help-seeking, and the distinction between clinically diagnosed and self-reported cases also affect how risk estimates should be interpreted. Family history indicates an elevated probability across groups; it is neither a prediction for a particular child nor proof of which biological mechanism is operating. MedlinePlus Genetics · O'Connell et al., 2025
Many variants contribute small effects
Bipolar disorder has a polygenic architecture. Instead of a single common inherited mutation that dictates the diagnosis, researchers find numerous genomic variants, each generally contributing a small increment to risk. Rare variants may also matter for subsets of people. These genetic influences overlap partly with those associated with other psychiatric conditions, which complicates any attempt to assign a specific genetic signature to bipolar disorder alone. MedlinePlus Genetics · O'Connell et al., 2025
The 2025 Nature multi-ancestry genome-wide association study combined 158,036 bipolar disorder cases and approximately 2.8 million controls. It identified 298 genome-wide significant loci and prioritized 36 credible genes through further genetic analyses. Signals implicated processes involving particular neuronal populations, including GABAergic interneurons and medium spiny neurons. These findings advance the search for mechanisms; they do not establish a complete causal chain from any identified variant to a person's symptoms. O'Connell et al., 2025
Importantly, the study observed differences across how participants were recruited and between bipolar I and bipolar II subtypes. Genomic samples also have uneven representation of ancestral groups, limiting how well some findings generalize. Replication, functional experiments, and inclusive research are required to determine which associations are relevant across populations and clinical presentations. O'Connell et al., 2025
Can genetic testing predict who will develop bipolar disorder?
Polygenic risk scores summarize the combined effects of many measured variants, usually using weights derived from large datasets. Such scores can be useful for research into group differences, shared liabilities, and biological pathways. At present, they do not diagnose bipolar disorder, reliably forecast its onset in an individual, or replace a mental health evaluation. Genetic risk can remain present throughout life without ever resulting in a manic or hypomanic episode. O'Connell et al., 2025 · NIMH
A person worried about inherited risk can discuss family history and concerns with a qualified clinician. Genetic counseling may help families understand what the existing evidence means, especially where several psychiatric diagnoses occur among relatives. A direct-to-consumer genetic score or family-history checklist should not be treated as a diagnostic result. MedlinePlus Genetics · NICE guideline CG185
Brain Biology: What Researchers Have Found
Brain circuits that regulate emotion, energy, and reward
The study of bipolar disorder involves networks governing emotional evaluation, motivation, reward learning, behavioral control, and responses to changing circumstances. Researchers examine how communication among brain areas and cell populations may relate to changes in mood and activation. The relevant pathways are complex and extend beyond one brain region. Genomic evidence suggesting specific neuronal cell types provides hypotheses to test, while imaging studies identify group-level differences rather than a single characteristic brain pattern shared by everyone with the condition. O'Connell et al., 2025 · NIMH
In a large ENIGMA consortium analysis, magnetic resonance imaging data from 6,503 participants were used to assess differences in cortical characteristics associated with bipolar disorder. The results reveal patterns across groups, but they are shaped by variation in participants' illness histories, medication exposure, and other factors. The presence of a statistical average difference does not tell a clinician whether a particular scan represents bipolar disorder. Hibar et al., 2018
An imaging difference can sometimes reflect susceptibility, consequences of repeated episodes, treatment, comorbid conditions, sleep, or multiple influences acting together. Cross-sectional studies comparing people at one time point are often unable to establish which came first. Studies following people before their first episode, with repeated measurements and careful consideration of medication exposure, are especially important for resolving these questions. Hibar et al., 2018 · NIMH
Neurotransmitters, signaling, and cellular hypotheses
Dopamine, glutamate, GABA, intracellular calcium signaling, and processes involving synapses and neuronal activity are among the subjects of bipolar disorder research. Their plausibility follows from converging genomic, pharmacological, cellular, and circuit-level findings. However, it would overstate the evidence to say bipolar disorder is simply caused by too much dopamine, too little serotonin, or one measurable chemical imbalance. A treatment acting on a signaling system does not prove that dysfunction in that system was the original cause of the illness. O'Connell et al., 2025 · NIMH
Other research examines inflammation, stress-hormone regulation, mitochondrial function, and cellular energy metabolism. These are active areas of scientific inquiry, with findings that vary by study design, illness phase, medication, physical health, and clinical population. The evidence does not support any one of them as a universal explanation or clinically validated standalone blood test for bipolar disorder. NIMH · VA/DoD guideline, 2023
Why there is no bipolar brain scan or blood test
Diagnosis rests on an assessment of sustained mood-and-energy episodes and their longitudinal course, including changes in sleep, behavior, duration, severity, and impairment. Clinicians consider other medical and psychiatric explanations. Brain imaging, genetic tests, and inflammatory markers are not established as individual diagnostic tests for bipolar I or bipolar II disorder. The absence of an abnormal scan does not exclude the disorder, and an unusual scan does not establish it. NICE guideline CG185 · VA/DoD guideline, 2023
Sleep and Circadian Rhythms: A Two-Way Relationship
The circadian system coordinates approximately 24-hour patterns of sleep, wakefulness, alertness, hormone release, and other biological functions. Bipolar mood episodes commonly involve altered sleep and activity, and sleep–wake disruptions can precede shifts in mood. Evidence reviewed by the International Society for Bipolar Disorders links circadian regulation to mood-related traits and bipolar phenomena across biological and behavioral levels. The researchers also emphasize substantial uncertainty about specificity and causal direction. McCarthy et al., 2022
In mania, a markedly reduced need for sleep can be a core symptom: a person may sleep very little and still feel unusually energized. That differs from ordinary insomnia, in which a person wants to sleep and often feels exhausted. Insufficient sleep, irregular sleep schedules, shift work, travel across time zones, and disrupted routines may also aggravate vulnerability or precede relapse for some individuals. The exact effects differ among people and cannot be used alone to diagnose bipolar disorder. NIMH · McCarthy et al., 2022
Because sleep and mood influence one another, a change in sleep may be an early warning sign, a contributing stressor, a symptom of an episode, or several of these at once. Clinical care looks for the direction and timing of changes rather than labeling every sleepless night as the cause of mania. Our article on bipolar disorder and sleep examines this relationship in the context of symptoms and relapse prevention. McCarthy et al., 2022
Environmental Factors and Life Experiences
Childhood adversity and trauma
Childhood maltreatment and adversity are associated with several unfavorable outcomes among people diagnosed with bipolar disorder. A systematic review and meta-analysis found associations between histories of childhood maltreatment and earlier onset, greater symptom severity, some comorbid conditions, and a more complicated course. This evidence concerns a statistically observed relationship between exposure and outcomes; it does not establish that a particular childhood event caused a particular person's bipolar disorder. Agnew-Blais and Danese, 201600544-1)
There are several plausible pathways through which adversity could affect emotional regulation, stress responses, sleep, substance exposure, access to support, and subsequent mental health. Adversity can also be associated with other factors that are difficult to separate in observational studies. People who experience trauma may develop many different outcomes, including no psychiatric disorder, while bipolar disorder can occur in people who report no significant childhood adversity. Trauma-informed assessment helps clinicians address what a person has experienced without presuming an explanation for their diagnosis. Agnew-Blais and Danese, 201600544-1) · Bortolato et al., 2017
Major life events, chronic stress, and social circumstances
Bereavement, relationship disruption, financial strain, violence, unstable housing, discrimination, and other intense or persistent stressors may contribute to mental health difficulties and can coincide with bipolar episode onset or recurrence. The World Health Organization recognizes biological, psychological, social, and structural influences on the condition's trajectory and outcomes. Their clinical significance depends on the person's context, resources, other health conditions, and underlying vulnerability. WHO, 2026
Stressful events sometimes precede a first episode, but retrospective reports of such events are susceptible to recall bias. A developing mood episode may itself alter relationships, finances, work, or sleep before its signs are recognized, making cause and consequence especially difficult to disentangle. Researchers therefore examine prospective records and repeated assessments, while acknowledging that observed temporal order alone does not eliminate confounding. Bortolato et al., 2017 · NICE guideline CG185
Supportive relationships, access to timely care, stable housing and working conditions, and opportunities to maintain regular routines can influence coping and recovery. Identifying environmental stressors can guide practical support without reducing a complex illness to someone's attitude, resilience, choices, or family dynamics. WHO, 2026
Alcohol, cannabis, and other substances
Substance use is clinically important because it can alter sleep and activation, worsen symptoms, affect treatment, and complicate the distinction between an independent bipolar disorder and substance- or medication-induced mood symptoms. Alcohol and drugs may affect the condition's onset and course, according to the WHO. None of these associations means that everyone who uses a substance will develop bipolar disorder or that substance exposure explains all cases. WHO, 2026 · NICE guideline CG185
A 2024 systematic review of 78 studies reported associations between cannabis use and greater depressive or manic symptoms, increased likelihood of mood disorder outcomes, and less favorable prognosis among people with mood disorders. Interpretation requires care: many studies are observational, cannabis exposure varies widely, and the contribution of pre-existing symptoms and other confounders can be difficult to isolate. Cannabis is a relevant risk and clinical discussion, not an established sole cause of bipolar disorder. Sorkhou, Dent, and George, 2024
Stimulants, certain medications, and substances can produce symptoms resembling hypomania or mania. The evaluating clinician considers the timeline of use, withdrawal, symptoms continuing outside exposure, medical conditions, and any previous independent episodes. Medication-associated mood elevation requires professional review of the drug and clinical history. Someone taking prescribed medication should not stop or change it independently based on a suspected connection. NICE guideline CG185 · VA/DoD guideline, 2023
Other proposed environmental explanations
Research has investigated prenatal and obstetric events, infections, inflammatory exposures, head injury, seasonality, and other environmental candidates. Associations for many of these are inconsistent or limited by small studies, retrospective exposure measurement, population differences, and confounding. Umbrella reviews that assess the credibility of environmental associations illustrate why a statistically significant result by itself is insufficient to establish causality. Bortolato et al., 2017
A practical reading rule is to ask whether the finding concerns the probability of ever developing bipolar disorder, the severity of an established illness, or the chance of another episode. Also ask whether a relationship remained after adjustment for relevant alternative explanations, whether it was replicated, and whether the study could establish that exposure preceded the outcome. These questions often matter more than the size of an attention-grabbing headline. Bortolato et al., 2017
How Genetics and Environment May Interact
Genetic liability and environmental conditions can be studied together rather than as two independent lists of causes. A person may inherit vulnerabilities affecting mood regulation, circadian timing, or sensitivity to stress, while life circumstances influence the expression of those vulnerabilities. This general model is consistent with current research, but an exact gene-by-event formula able to predict a specific person's bipolar onset has not been established. NIMH · O'Connell et al., 2025
The phrase gene–environment interaction has a precise research meaning: the estimated effect of an exposure may differ according to genetic background, or vice versa. Many studies cannot yet distinguish true interaction from measurement limitations or correlations between genes and the environments people encounter. Broad claims that trauma 'switches on a bipolar gene' turn a research hypothesis into an unwarranted personal explanation. O'Connell et al., 2025 · Bortolato et al., 2017
An accessible way to think about the evidence is to separate long-term susceptibility from near-term changes that can make symptoms more likely to emerge. The first includes inherited vulnerability; the second may involve acute sleep disruption, major stress, substance exposure, or other health changes. The interaction between them differs among individuals, and many episodes have no clearly identifiable precipitating event. NIMH · McCarthy et al., 2022
Does Bipolar I Have Different Causes From Bipolar II?
Bipolar I disorder is defined by the occurrence of a manic episode; bipolar II disorder involves hypomania and major depressive episodes without a history of full mania. Both diagnoses can involve inherited liability and overlapping biological and environmental processes. Researchers have identified differences in genetic associations between subtypes, but these are findings across studied groups, not validated diagnostic mechanisms for individual patients. Bipolar II is not simply a milder biological version of bipolar I. O'Connell et al., 2025 · NIMH
Some samples group different bipolar subtypes together, and results may be influenced by how clinicians recognized mania or hypomania, how often people presented for depressive symptoms, and the methods used to recruit participants. Genetic distinctions do not authorize inferring subtype from family resemblance, personality, sleep habits, or a home test. O'Connell et al., 2025
Why Bipolar Disorder Often First Appears in Adolescence or Early Adulthood
Bipolar disorder often becomes clinically apparent during adolescence or early adulthood, although onset and recognition vary widely. Changes in sleep–wake schedules, psychosocial demands, substance exposure, and developmental factors may interact with vulnerability during these periods. The existence of such circumstances does not mean adolescence itself causes bipolar disorder or that every adolescent with mood changes is showing bipolar symptoms. NIMH · NIMH: Bipolar Disorder in Children and Teens
For children and teenagers, clinical assessment must examine symptom duration, clear departure from developmental baseline, intensity, impairment, and persistence across settings and time. NICE recommends specialist longitudinal assessment and cautions against making a bipolar diagnosis in young people solely because they have depression and a family history. Developmental evidence cannot simply be replaced with findings from adult studies. NICE guideline CG185
What Triggers a Bipolar Episode?
A trigger is an event or change associated with the emergence of an episode in someone already susceptible to bipolar mood episodes. Examples a clinician may explore include sustained sleep loss, significant stress, changes in daily routine, substance use, medication changes, and physical health events. The person's own pattern, observed over time, carries more clinical value than a generic list. A trigger may increase near-term risk without explaining why the condition originally developed. McCarthy et al., 2022 · NICE guideline CG185
Some episodes have no recognized trigger. Conversely, many people experience sleep loss or stressful life events without developing mania. Clinicians look for a substantial and sustained change in mood and energy, associated symptoms, and functional consequences, while accounting for substances and alternative diagnoses. Tracking personal patterns can aid early recognition, but symptom tracking and ordinary mood changes are not diagnostic tests. NIMH · VA/DoD guideline, 2023
An important clinical distinction is between an inability to sleep accompanied by fatigue and a reduced need for sleep accompanied by unusual energy, pressured speech, accelerated thinking, increased activity, or markedly impaired judgment. When these changes accumulate or escalate, professional assessment should take priority over trying to identify their cause at home. NIMH
Can Stress Alone Cause Bipolar Disorder?
Stress can matter greatly to a person's experiences and course of illness. Scientific studies do not establish that one stressful event is a sufficient, specific cause of bipolar disorder across individuals. Most people exposed to major stress do not develop bipolar disorder, and some people with bipolar disorder cannot identify an exceptional stressor before onset. Risk depends on a wider combination of inherited, biological, environmental, and contextual factors. Bortolato et al., 2017 · WHO, 2026
Stress reduction can be a useful part of care because it addresses burden, sleep, relationships, and functioning. It should be presented as support for health and relapse prevention, with realistic expectations, rather than as proof that the illness was self-created or can be cured through willpower. NICE guideline CG185 · WHO, 2026
Are Parenting Styles or Personal Choices to Blame?
The established genetic and clinical evidence gives no basis for blaming a parent, partner, or person living with bipolar disorder for causing the diagnosis through ordinary parenting decisions, personality, emotional weakness, or lack of effort. Adverse experiences deserve recognition and treatment, and family environments can influence stress and support; these conclusions are compatible with the fact that bipolar disorder has complex, partly inherited determinants. NIMH · Agnew-Blais and Danese, 201600544-1)
Family involvement can be constructive when the person consents and the relationships are safe: shared knowledge about episode patterns, realistic plans for sleep and emergencies, and communication with clinicians may help. Clinical guidelines recommend carer-focused education and assessment of social circumstances while respecting the patient's preferences and wellbeing. NICE guideline CG185
How Do Clinicians Decide Whether Symptoms Are Bipolar Disorder?
Knowing that a person has genetic vulnerability, a history of adversity, or irregular sleep does not establish a diagnosis. Bipolar disorder is identified through clinical episodes. A manic episode involves a distinct and sustained change in mood and increased energy or activity, together with associated symptoms and substantial impairment, need for hospitalization, or psychotic features. Hypomania has a shorter minimum duration and does not involve the level of marked impairment or psychosis that characterizes mania. Major depressive episodes and the sequence of episodes affect classification. NIMH · NICE guideline CG185
A clinician asks when symptoms began; how long they lasted; what changed in sleep, energy, mood, speech, judgment, and functioning; whether similar periods occurred before; and whether family members can supply a useful history with permission. The assessment also considers medications, substances, physical health conditions, unipolar depression, psychotic conditions, ADHD, and other explanations as clinically relevant. NICE guideline CG185 · VA/DoD guideline, 2023
The diagnostic process is explained in detail in How Is Bipolar Disorder Diagnosed? Clinical Assessment Explained. If you need the diagnostic categories and episode distinctions first, begin with our overview of bipolar disorder.
Why family history and risk factors cannot replace an evaluation
A positive family history can make clinicians more attentive to a reported manic or hypomanic episode, particularly when someone is being assessed for depression. However, exposure histories and screening questionnaires cannot confirm the condition. Equally, no known affected relative and no recognized trauma do not rule it out. Longitudinal episode evidence and differential diagnosis determine clinical classification. NICE guideline CG185 · NIMH
What Understanding the Causes Changes About Care
An explanation of risk does not itself determine treatment. Care depends on the diagnosis, current phase of illness, previous response, comorbid conditions, safety considerations, and the person's goals. Acute mania, bipolar depression, and prevention of future episodes are distinct clinical problems with different evidence bases. Medication, psychotherapy, monitoring, and practical support may all contribute, under professional supervision. CANMAT/ISBD 2023 update · VA/DoD guideline, 2023
A person with bipolar disorder may benefit from recognizing early mood-and-sleep changes, discussing stressors and substance use openly with clinicians, maintaining sustainable routines, arranging follow-up, and developing an individualized relapse plan. These practices can improve recognition and support management; they do not reverse inherited susceptibility or guarantee prevention of episodes. NICE guideline CG185 · McCarthy et al., 2022
Prescribed medicines, including lithium, lamotrigine, valproate, antipsychotics, and antidepressants when clinically appropriate, have different roles and safety requirements. They are not interchangeable treatments for every phase of bipolar disorder. Monitoring and reproductive safety considerations can be important, and medication changes should be discussed with the prescribing clinician rather than undertaken independently. CANMAT/ISBD 2023 update · NICE guideline CG185
When symptoms require urgent attention
Seek urgent professional assessment when there is rapidly escalating energy with very little sleep, severe impulsivity or disinhibition, delusions or hallucinations, substantial loss of judgment, inability to care for basic needs, or concern that someone may harm themselves or others. These situations call for assessment of immediate safety and possible mania, psychosis, substance effects, or other medical causes. If there is immediate danger, contact local emergency services or an emergency department. NICE guideline CG185 · WHO, 2026
What Researchers Still Need to Establish
Several major questions remain open. Scientists are still working to connect genetic loci to mechanisms that operate across development, explain why people with similar inherited liability have different outcomes, distinguish predisposition from effects of repeated episodes, and identify which environmental associations are robustly causal. More diverse prospective samples, consistent diagnostic definitions, repeated biological measures, and careful accounting for treatment exposure are essential. O'Connell et al., 2025 · Hibar et al., 2018 · Bortolato et al., 2017
A scientifically useful explanation preserves the difference between what has been consistently observed and what is still being tested. Family aggregation and polygenic liability are strongly supported. Circadian and brain findings provide converging biological research directions. Many claims about one specific exposure, biomarker, or neurotransmitter as the decisive cause require stronger evidence. That distinction protects both accurate science and patients from unwarranted certainty. O'Connell et al., 2025 · McCarthy et al., 2022
Frequently Asked Questions
Is bipolar disorder something you are born with?
A person can be born with inherited susceptibility to bipolar disorder, while the clinical condition generally becomes recognizable when mood episodes occur later in life. Most genetically susceptible people cannot be individually identified by a diagnostic genetic test, and inherited risk alone does not establish a diagnosis. NIMH · O'Connell et al., 2025
Can someone develop bipolar disorder without a family history?
Yes. Family history increases risk but is neither necessary nor sufficient for the condition to occur. Relatives may have no diagnosed disorder, different psychiatric conditions, or histories that are unknown. Clinical episodes and longitudinal assessment remain central. MedlinePlus Genetics · NICE guideline CG185
Can trauma cause bipolar disorder years later?
Trauma and childhood maltreatment have been associated with elevated risk indicators and less favorable clinical outcomes, but researchers cannot infer from one person's exposure that trauma caused that person's bipolar disorder. A history of trauma deserves sensitive care regardless of whether a bipolar diagnosis is present. Agnew-Blais and Danese, 201600544-1)
Can lack of sleep cause bipolar disorder?
Sleep disruption can affect mood and may precipitate or accompany episodes in vulnerable individuals. It is also a symptom during some episodes. Evidence does not establish that occasional poor sleep creates bipolar disorder in someone without vulnerability. McCarthy et al., 2022
Are bipolar disorder and depression caused by the same things?
They have some overlapping genetic and environmental associations, while bipolar disorders are clinically distinguished by mania or hypomania and related episode patterns. Shared risk factors do not make the conditions identical, and treatment decisions differ substantially. For bipolar-specific depressive episodes, read Bipolar Depression: Symptoms, Diagnosis, and Course. O'Connell et al., 2025 · CANMAT/ISBD 2023 update
Is bipolar disorder caused by a chemical imbalance?
The phrase oversimplifies ongoing research. Neural signaling systems are relevant to mood regulation, but no one neurotransmitter level or routine chemical test defines bipolar disorder. Genomic and brain research suggest multiple interacting biological pathways. NIMH · O'Connell et al., 2025
If the cause is uncertain, can bipolar disorder still be treated?
Yes. Clinical care does not require identifying one root cause in each individual. Evidence-based treatment targets current episodes, recurrence prevention, functioning, and safety. Treatment is tailored to illness phase and personal circumstances, with ongoing professional monitoring. VA/DoD guideline, 2023 · CANMAT/ISBD 2023 update
Related Articles
Bipolar Disorder: Symptoms, Types, Diagnosis, and Treatment — the main guide to episodes, diagnostic categories, and treatment.
How Is Bipolar Disorder Diagnosed? Clinical Assessment Explained — how clinicians distinguish a mood episode from risk factors and other conditions.
Bipolar Disorder and Sleep: Mood Episodes, Circadian Rhythms, and Prevention — a closer look at sleep changes, biological timing, and relapse.
Bipolar Depression: Symptoms, Diagnosis, and Course — bipolar depressive episodes and their clinical assessment.
References
Agnew-Blais, J., & Danese, A. (2016). Childhood maltreatment and unfavourable clinical outcomes in bipolar disorder: A systematic review and meta-analysis. The Lancet Psychiatry, 3(4), 342–349. https://doi.org/10.1016/S2215-0366(15)00544-100544-1)
Bortolato, B., Köhler, C. A., Evangelou, E., et al. (2017). Systematic assessment of environmental risk factors for bipolar disorder: An umbrella review of systematic reviews and meta-analyses. Bipolar Disorders, 19(2), 84–96. https://doi.org/10.1111/bdi.12490
Hibar, D. P., Westlye, L. T., van Erp, T. G. M., et al. (2018). Cortical abnormalities in bipolar disorder: An MRI analysis of 6,503 individuals from the ENIGMA Bipolar Disorder Working Group. Molecular Psychiatry, 23, 932–942. https://doi.org/10.1038/mp.2017.73
Keramatian, K., Chithra, N. K., & Yatham, L. N. (2023). The CANMAT and ISBD guidelines for the treatment of bipolar disorder: Summary and a 2023 update of evidence. Focus, 21(4), 344–353. https://doi.org/10.1176/appi.focus.20230009
McCarthy, M. J., Gottlieb, J. F., Gonzalez, R., et al. (2022). Neurobiological and behavioral mechanisms of circadian rhythm disruption in bipolar disorder: A critical multi-disciplinary literature review and agenda for future research from the ISBD task force on chronobiology. Bipolar Disorders, 24(3), 232–263. https://doi.org/10.1111/bdi.13165
National Institute for Health and Care Excellence. (2014; updated). Bipolar disorder: Assessment and management (Clinical guideline CG185). https://www.nice.org.uk/guidance/cg185/chapter/recommendations
National Institute of Mental Health. (n.d.). Bipolar disorder in children and teens. U.S. National Institutes of Health. https://www.nimh.nih.gov/health/publications/bipolar-disorder-in-children-and-teens
National Institute of Mental Health. (n.d.). Bipolar disorder. U.S. National Institutes of Health. https://www.nimh.nih.gov/health/publications/bipolar-disorder
National Library of Medicine. (n.d.). Bipolar disorder. MedlinePlus Genetics. https://medlineplus.gov/genetics/condition/bipolar-disorder/
O'Connell, K. S., Koromina, M., van der Veen, T., et al. (2025). Genomics yields biological and phenotypic insights into bipolar disorder. Nature, 639, 968–975. https://doi.org/10.1038/s41586-024-08468-9
Sorkhou, M., Dent, E. L., & George, T. P. (2024). Cannabis use and mood disorders: A systematic review. Frontiers in Public Health, 12, 1346207. https://doi.org/10.3389/fpubh.2024.1346207
U.S. Department of Veterans Affairs & U.S. Department of Defense. (2023). VA/DoD clinical practice guideline for the management of bipolar disorder. https://healthquality.va.gov/HEALTHQUALITY/guidelines/mh/bd/index.asp
World Health Organization. (2026, September 11). Bipolar disorder. https://www.who.int/news-room/fact-sheets/detail/bipolar-disorder/